Travere Therapeutics to Report First Quarter 2026 Financial Results
Go back to Travere Therapeutics to Report First Quarter 2026 Financial Results| (NASDAQ: TVTX) | Delayed: 65.22 -0.49 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.71 | 52 Week High | $ | |||
| Open | $65.78 | 52 Week Low | $ | |||
| Day High | $65.80 | P/E | N/A | |||
| Day Low | $63.71 | EPS | $ | |||
| Volume | 1,035,401 | |||||

